supported by grants from the National Key R&D Program of China(2021YFA1300801 and 2018YFA0900801);National Natural Science Foundation of China(82172243 and 82372223);Fundamental Research Funds for the Central Universities(2042021kf0220 and 2042022dx0003).
The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is still epidemic around the world.The manipulation of SARS-CoV-2 is restricted to biosafety level 3 laboratories(BSL-3).In this study,we developed a SARS...